Angelina I. Londono-Joshi, Ph.D.
Affiliations: | 2013 | Pathology | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
Pathology, Molecular Biology, Cell BiologyGoogle:
"Angelina Londono-Joshi"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Donald J. Buchsbaum | grad student | 2013 | UAB | |
| (Investigation of death receptor-5 mediated apoptosis and inhibition of Wnt/beta-catenin signaling in basal-like breast cancer stem cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Arend RC, Londoño-Joshi AI, Gangrade A, et al. (2018) Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer. Oncotarget. 9: 19459 |
| Arend RC, Londoño-Joshi AI, Gangrade A, et al. (2016) Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer. Oncotarget |
| Che P, Yang Y, Han X, et al. (2015) S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase. Scientific Reports. 5: 8453 |
| Arend RC, Londoño-Joshi AI, Samant RS, et al. (2014) Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer. Gynecologic Oncology. 134: 112-20 |
| Londoño-Joshi AI, Arend RC, Aristizabal L, et al. (2014) Effect of niclosamide on basal-like breast cancers. Molecular Cancer Therapeutics. 13: 800-11 |
| Fauci JM, Sabbatino F, Wang Y, et al. (2014) Monoclonal antibody-based immunotherapy of ovarian cancer: targeting ovarian cancer cells with the B7-H3-specific mAb 376.96. Gynecologic Oncology. 132: 203-10 |
| Haygood CLW, Arend RC, Londono-Joshi A, et al. (2014) Ovarian cancer ascites stem cell population compared to primary tumor Gynecologic Oncology. 133: 122 |
| Arend RC, Londoño-Joshi AI, Straughn JM, et al. (2013) The Wnt/β-catenin pathway in ovarian cancer: a review. Gynecologic Oncology. 131: 772-9 |
| Lin C, Lu W, Zhang W, et al. (2013) The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells. Plos One. 8: e58102 |
| Swindall AF, Londoño-Joshi AI, Schultz MJ, et al. (2013) ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines. Cancer Research. 73: 2368-78 |